ZMapp is an experimental therapeutic drug that was developed for the treatment of Ebola virus disease. It is a type of monoclonal antibody therapy, which means it is designed to target and neutralize the Ebola virus in the body. ZMapp was created by combining three different monoclonal antibodies that can bind to the virus and help the immune system fight off the infection.
Articles by others on the same topic
There are currently no matching articles.